MWG Biotech and Eurofins Medigenomix have developed the Geneius software for gene synthesis.
Geneius features the automatic adaptation of the codon usage, which can optimise DNA sequences for protein expression in a target organism.
Geneius also prevents direct or indirect repeats and hairpin structures in the optimised sequence, solving problems during transcription or translation.
Unlike other codon-adaptation programs, Geneius does not affect codon-adaptation quality when optimising for other features.
MWG Biotech and Eurofins Medigenomix offer in-house gene-synthesis services, including oligonucleotide production, design and processing of gene synthesis and final quality control of the genes.
